Lower ratings of pain intensity in older adults lead to underestimation of disease activity in patients with rheumatoid arthritis
Journal Title: International Journal of Clinical Rheumatology - Year 2017, Vol 12, Issue 2
Abstract
Background: To investigate the influence of age on the components of the 28-joint Disease Activity Score (DAS28)-C-Reactive Protein (CRP) in patients with Rheumatoid Arthritis (RA) and whether DAS28-CRP can be equally interpreted in all age groups. Methods: The proportion of CRP and patient reported components of the DAS28 (DAS-P) were analyzed and compared between 2 age groups (younger RA <60, older RA ≥ 60) using Mann-Whitney U test. Inflammatory disease burden in the joint was calculated by modified DAS28 (MDAS28=0.49 x ln(C-Reactive Protein (CRP))+0.15 x swollen joint count 28+0.22 x physician global assessment (PhGA)+1). Multivariate analyses were used to design models best predicting the effect of age on CRP, the proportion of CRP, inflammation level calculated by MDAS28, DAS-P, and pain levels. Results: CRP and the proportion of CRP in DAS28-CRP were not influenced by age. MDAS28 did not increase with age but was associated with disease duration and anti-tumor necrosis factor (TNF) therapy. DAS-P and pain level had significant negative association with age. In subjects with moderate inflammation (defined by MDAS28 score above 50 percentile, N=370), older RA subjects (N=189) had lower pain level, tender joint count, patient and physician global assessment, DAS28-CRP than younger subjects (n=157). Conclusions: CRP, proportion of CRP in DAS28-CRP, and MDAS28 were not influenced by age but the proportion of subjective components of DAS28-CRP and pain level decreased with age. Therefore, disease activity could be underestimated by DAS28-CRP in older RA patients.
Authors and Affiliations
Yong Gil Hwang, Ajay D Wasan, June Feng, Heather Eng, Jason Lyons, Anthony Fabio, Larry W Moreland
Keywords
Related Articles
- EP ID EP603276
- DOI -
- Views 53
- Downloads 0
Rheumatology to hepatology cross talk: An evidence based update on the treat to target strategy in hepatitis-C related extrahepatic autoimmune syndromes
Hepatitis C virus (HCV) is a universally identified major epidemiological health problem with an estimated reservoir of almost 200 million or 3% of the global population. In the year 2013, the WHO declared viral hepatiti...
Hearing loss in systemic sclerosis - clinically important, potentially treatable and often overlooked
Systemic sclerosis (SSc) is one of the most complex systemic autoimmune diseases [1] characterized by cutaneous and visceral fibrosis, immune dysregulation and vasculopathy. Although rheumatologists can address hearing l...
Mobile health applications in rheumatology: Could they improve our care and research?
With>165,000 mobile health apps available on iTunes and Google Play mHealth is a rapidly growing field, which generated high expectations for the improvement of our health care. We identify two uses for mHealth in the fi...
Chikungunya arthritis: an emerging rheumatologic problem
Chikungunya virus (CHIKV) is an alphavirus that belongs to the Togaviridae family, transmitted primarily by the bite of the mosquito Aedes aegypti. Although occurrence of CHIK outbreaks has been sporadically reported in...
Predictors of quality of life improvement following peer mentoring in AfricanAmerican women with systemic lupus erythematosus (sle)
Background: Systemic lupus erythematosus is a complex autoimmune disorder with heterogeneous presentation. Behavioral interventions have had mixed effects among this population, particularly among African American women,...